© 2004 by Oxford University Press
© 2004 Oxford University Press
BRIEF COMMUNICATION |
Effects of Angiogenesis Inhibitors on Vascular Network Formation by Human Endothelial and Melanoma Cells
Affiliations of authors: Childrens Memorial Research Center, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL (REBS, EAS, ARH, LMG, DAK, MJCH); Angiogenesis Laboratory, Department of Pathology/Internal Medicine, Research Institute for Growth and Development (GROW), Maastricht University and Hospital, Maastricht, The Netherlands (DWJVDS, AWG); Department of Pharmacology, University of Minnesota, Minneapolis (YY)
Correspondence to: Mary J. C. Hendrix, PhD, Childrens Memorial Research Center, Northwestern University Feinberg School of Medicine, 2300 Childrens Plaza, Box 222, Chicago, IL 60614-3394 (e-mail: mjchendrix{at}childrensmemorial.org)
Endothelial cells involved in vasculogenesis and angiogenesis are key targets in cancer therapy. Recent evidence suggests that tumor cells can express some genes typically expressed by endothelial cells and form extracellular matrixrich tubular networks, phenomena known as vasculogenic mimicry. We examined the effects of three angiogenesis inhibitors (i.e., anginex, TNP-470, and endostatin) on vasculogenic mimicry in human melanoma MUM-2B and C8161 cells and compared them with their effects in human endothelial HMEC-1 and HUVEC cells. Anginex, TNP-470, and endostatin markedly inhibited vascular cord and tube formation by HMEC-1 and HUVEC cells in vitro, whereas tubular network formation by MUM-2B and C8161 cells was relatively unaffected. Endothelial cells expressed higher mRNA and protein levels for two putative endostatin receptors,
5 integrin and heparin sulfate proteoglycan 2, than melanoma cells, suggesting a mechanistic basis for the differential response of the two cell types to angiogenesis inhibitors. These findings may contribute to the development of new antivascular therapeutic agents that target both angiogenesis and tumor cell vasculogenic mimicry.
This article has been cited by other articles:
![]() |
D. Liu, M. Iruthayanathan, L. L. Homan, Y. Wang, L. Yang, Y. Wang, and J. S. Dillon Dehydroepiandrosterone Stimulates Endothelial Proliferation and Angiogenesis through Extracellular Signal-Regulated Kinase 1/2-Mediated Mechanisms Endocrinology, March 1, 2008; 149(3): 889 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, S. Zhang, D. Zhang, X. Yin, S. Wang, Y. Gu, and Y. Wang Doxycycline Influences Microcirculation Patterns in B16 Melanoma Experimental Biology and Medicine, November 1, 2007; 232(10): 1300 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Robertson Mig-7 Linked to Vasculogenic Mimicry Am. J. Pathol., May 1, 2007; 170(5): 1454 - 1456. [Full Text] [PDF] |
||||
![]() |
A. P. Petty, K. L. Garman, V. D. Winn, C. M. Spidel, and J. S. Lindsey Overexpression of Carcinoma and Embryonic Cytotrophoblast Cell-Specific Mig-7 Induces Invasion and Vessel-Like Structure Formation Am. J. Pathol., May 1, 2007; 170(5): 1763 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W.J. van der Schaft, F. Hillen, P. Pauwels, D. A. Kirschmann, K. Castermans, M. G.A. oude Egbrink, M. G.B. Tran, R. Sciot, E. Hauben, P. C.W. Hogendoorn, et al. Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia Cancer Res., December 15, 2005; 65(24): 11520 - 11528. [Abstract] [Full Text] [PDF] |
||||



